https://www.selleckchem.com/pr....oducts/cefodizime-so
Oral squamous cell carcinoma (OSCC) has increased in incidence from 1990 to 2017, especially in South and Southeast Asia. It is often diagnosed at an advanced stage with a poor prognosis. Therefore, early detection of OSCC is essential to improve the prognosis of OSCC. This study aims to identify the differentially expressed serum proteins as potential biomarkers for oral squamous cell carcinoma (OSCC). Comparative proteomics profiling of serum samples from OSCC patients, oral potentially malignant disorder (OPMD) patients, an